Our History
Daliom Biopharmaceuticals was founded in 2010 by a group of scientists from the University of Zurich who had been working on developing new drugs for several years. The company’s goal was to create a biopharmaceutical company that would specialize in developing and manufacturing drugs based on biological principles.
The founders were driven by a desire to create a company that would use the latest scientific advances to develop innovative and effective drugs. They believed that by using biological principles, they could create drugs that were safer and more effective than those produced by traditional pharmaceutical companies.
Over the years, Daliom Biopharmaceuticals has grown into one of the leading biopharmaceutical companies in the world. The company has a strong research and development team and a global network of partners. Daliom’s research focuses on developing drugs for a wide range of diseases, including cancer, heart disease, and Alzheimer’s disease.
In recent years, Daliom has received numerous awards for its research and development efforts, including the Nobel Prize in Medicine. The company is also actively engaged in partnerships with other biopharmaceutical companies to collaborate on research projects and develop new drugs.
